REVISION TO PRIOR PERIOD FINANCIAL STATEMENT (Tables)

6 Months Ended

Jan. 31, 2023

Prior Period Adjustment [Abstract]

Schedule Of Condensed Financial Statements

	As of July 31, 2022
	As Previously Reported			Adjustments			As Corrected
	(in thousands)
Condensed Consolidated Balance Sheet:
Accrued expenses and other current liabilities	$	49,232		$	10,336		$	59,568
Total current liabilities	$	1,150,224		$	10,336		$	1,160,560
Total liabilities	$	3,155,917		$	10,336		$	3,166,253
Accumulated deficit	$	(4,368,026	)	$	(10,336	)	$	(4,378,362	)
Total stockholders’ deficit	$	(790,168	)	$	(10,336	)	$	(800,504	)

Schedule of Condensed Consolidated Statement of Operations

	Three Months Ended January 31, 2022
	As Previously Reported			Adjustments			As Corrected
	(in thousands)
Condensed Consolidated Statement of Operations:
Sales and marketing	$	241,633		$	93		$	241,726
Research and development	$	141,608		$	262		$	141,870
Total operating expenses	$	427,532		$	355		$	427,887
Loss from operations	$	(94,420	)	$	(355	)	$	(94,775	)
Loss before provision for income taxes	$	(109,752	)	$	(355	)	$	(110,107	)
Net loss	$	(115,061	)	$	(355	)	$	(115,416	)
Net loss per share attributable to Class A and Class    B common stockholders—basic and diluted	$	(0.53	)	$	(0.00	)	$	(0.53	)

	Six Months Ended January 31, 2022
	As Previously Reported			Adjustments			As Corrected
	(in thousands)
Condensed Consolidated Statement of Operations:
Sales and marketing	$	491,666		$	186		$	491,852
Research and development	$	285,874		$	523		$	286,397
Total operating expenses	$	861,859		$	709		$	862,568
Loss from operations	$	(231,676	)	$	(709	)	$	(232,385	)
Loss before provision for income taxes	$	(525,557	)	$	(709	)	$	(526,266	)
Net loss	$	(534,913	)	$	(709	)	$	(535,622	)
Net loss per share attributable to Class A and Class    B common stockholders—basic and diluted	$	(2.46	)	$	(0.01	)	$	(2.47	)

	Three Months Ended January 31, 2022
	As Previously Reported			Adjustments			As Corrected
	(in thousands)
Condensed Consolidated Statement of Comprehensive Loss:
Net loss	$	(115,061	)	$	(355	)	$	(115,416	)
Comprehensive loss	$	(116,837	)	$	(355	)	$	(117,192	)

	Six Months Ended January 31, 2022
	As Previously Reported			Adjustments			As Corrected
	(in thousands)
Condensed Consolidated Statement of Comprehensive Loss:
Net loss	$	(534,913	)	$	(709	)	$	(535,622	)
Comprehensive loss	$	(537,340	)	$	(709	)	$	(538,049	)

Schedule of Condensed Consolidated Statement of Comprehensive Loss

Schedule Of Condensed Consolidated Statement of Cash Flows

	As Previously Reported			Adjustments			As Corrected
	(in thousands)
Condensed Consolidated Statement of Stockholders' Deficit:
Accumulated Deficit as of:
July 31, 2021	$	(3,627,355	)	$	(8,928	)	$	(3,636,283	)
October 31, 2021	$	(3,990,340	)	$	(9,282	)	$	(3,999,622	)
January 31, 2022	$	(4,105,401	)	$	(9,637	)	$	(4,115,038	)
July 31, 2022	$	(4,368,026	)	$	(10,336	)	$	(4,378,362	)
October 31, 2022	$	(4,467,142	)	$	(10,734	)	$	(4,477,876	)
Total Stockholders' Deficit as of:
July 31, 2021	$	(1,012,041	)	$	(8,928	)	$	(1,020,969	)
October 31, 2021	$	(698,739	)	$	(9,282	)	$	(708,021	)
January 31, 2022	$	(725,617	)	$	(9,637	)	$	(735,254	)
July 31, 2022	$	(790,168	)	$	(10,336	)	$	(800,504	)
October 31, 2022	$	(791,049	)	$	(10,734	)	$	(801,783	)
Net Loss for the Three Months Ended:
October 31, 2021	$	(419,852	)	$	(354	)	$	(420,206	)
January 31, 2022	$	(115,061	)	$	(355	)	$	(115,416	)
October 31, 2022	$	(99,116	)	$	(398	)	$	(99,514	)

Schedule Of Condensed Consolidated Stockholder's Deficit

	Six Months Ended January 31, 2022
	As Previously Reported			Adjustments			As Corrected
	(in thousands)
Condensed Consolidated Statement of Cash Flows:
Net loss	$	(534,913	)	$	(709	)	$	(535,622	)
Accrued expenses and other liabilities	$	(3,371	)	$	709		$	(2,662	)